United States · FDA National Drug Code directory
Meclizine Hydrochloride
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 76420-797_158f70ad-1608-c116-e063-6394a90a94c6
- Product NDC
- 76420-797
- Form
- TABLET
- Composition / generic term
- Meclizine Hydrochloride
- Labeler
- Asclemed USA, Inc.
- Marketing category
- NDA AUTHORIZED GENERIC
- Marketing start / end (source format)
- 20200115
- Source listing expiry
- 20261231
Source-listed ingredients
- MECLIZINE HYDROCHLORIDE — 12.5 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 TABLET in 1 BOTTLE (76420-797-01) · 76420-797-01
- 30 TABLET in 1 BOTTLE (76420-797-30) · 76420-797-30
- 60 TABLET in 1 BOTTLE (76420-797-60) · 76420-797-60
- 90 TABLET in 1 BOTTLE (76420-797-90) · 76420-797-90
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →